- Home
- PRQR vs HCAT Comparison
PRQR vs HCAT Comparison
Compare PRQR & HCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRQR
- HCAT
- Stock Information
- Founded
- PRQR 2012
- HCAT 2008
- Country
- PRQR Netherlands
- HCAT United States
- Employees
- PRQR N/A
- HCAT N/A
- Industry
- PRQR Biotechnology: Pharmaceutical Preparations
- HCAT Computer Software: Programming Data Processing
- Sector
- PRQR Health Care
- HCAT Technology
- Exchange
- PRQR Nasdaq
- HCAT Nasdaq
- Market Cap
- PRQR 179.1M
- HCAT 259.8M
- IPO Year
- PRQR 2014
- HCAT 2019
- Fundamental
- Price
- PRQR $2.35
- HCAT $3.89
- Analyst Decision
- PRQR Strong Buy
- HCAT Buy
- Analyst Count
- PRQR 8
- HCAT 11
- Target Price
- PRQR $8.88
- HCAT $8.00
- AVG Volume (30 Days)
- PRQR 365.1K
- HCAT 589.9K
- Earning Date
- PRQR 08-07-2025
- HCAT 08-06-2025
- Dividend Yield
- PRQR N/A
- HCAT N/A
- EPS Growth
- PRQR N/A
- HCAT N/A
- EPS
- PRQR N/A
- HCAT N/A
- Revenue
- PRQR $21,212,711.00
- HCAT $311,274,000.00
- Revenue This Year
- PRQR N/A
- HCAT $11.23
- Revenue Next Year
- PRQR N/A
- HCAT $9.71
- P/E Ratio
- PRQR N/A
- HCAT N/A
- Revenue Growth
- PRQR 85.91
- HCAT 4.88
- 52 Week Low
- PRQR $1.07
- HCAT $3.49
- 52 Week High
- PRQR $4.62
- HCAT $9.24
- Technical
- Relative Strength Index (RSI)
- PRQR 66.90
- HCAT 48.61
- Support Level
- PRQR $2.10
- HCAT $3.91
- Resistance Level
- PRQR $2.18
- HCAT $4.12
- Average True Range (ATR)
- PRQR 0.13
- HCAT 0.20
- MACD
- PRQR 0.01
- HCAT 0.02
- Stochastic Oscillator
- PRQR 56.92
- HCAT 59.83
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.
About HCAT Health Catalyst Inc
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.